Amishi Patel, MD
Nephrology · Evergreen Park, ILNPI 1063670719
Payments from drug & device makers
Across 9 payments — averaging $35.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vifor Pharma, Inc.$200
- Fresenius USA Marketing, Inc.$44
- Travere Therapeutics, Inc.$22
- Boehringer Ingelheim$19
- Abiomed$19
- Baxter Healthcare$13
What the payments were for
- Speaking & faculty fees$20063%
- Food & beverage$7624%
- Education$4113%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vifor Pharma, Inc. | 1 | $200 |
| Fresenius USA Marketing, Inc. | 2 | $44 |
| Travere Therapeutics, Inc. | 3 | $22 |
| Boehringer Ingelheim | 1 | $19 |
| Abiomed | 1 | $19 |
| Baxter Healthcare | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Veltassa$200
How this compares
$317 in reported general payments places this provider in the 30th percentile of 524 nephrology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LokelmaSodium Zirconium Cyclosilicate | 12 | $15,619 |
| Cinacalcet Hcl | 22 | $15,166 |
| Potassium Citrate ErPotassium Citrate | 27 | $4,313 |
| Calcitriol | 306 | $4,277 |
| Potassium Chloride | 46 | $2,482 |
| Sevelamer Carbonate | 14 | $2,267 |
| Hydralazine Hcl | 87 | $1,680 |
| Nifedipine ErNifedipine | 30 | $1,324 |
| Furosemide | 163 | $1,221 |
| Valsartan | 49 | $1,041 |
| Torsemide | 23 | $910 |
| Allopurinol | 72 | $856 |
| Losartan Potassium | 50 | $728 |
| Clonidine | 12 | $530 |
| Amlodipine Besylate | 39 | $507 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Evergreen Park
- Paul CrawfordEvergreen Park$3.1M
- Juan LermaEvergreen Park$351K
- Abraham ThomasEvergreen Park$295K
- Myles WolfChicago$22.4M
- Suneel UdaniHinsdale$6.8M
- Beatrice ConcepcionChicago$2.6M
- April KennedyChicago$1.8M
- Khaleel SayeedChicago$1.7M
- Woojin James ChonHines$1.1M
- Mohammed AhmedBolingbrook$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.